Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kumar Amresh | VP Program Management | 3 | $0 | $0 | 2024-05-06 |
| D'Andrea Carrie | VP Program Management | 3 | $0 | $0 | 2024-05-06 |
| Kohli Prashant | Chief Executive Officer | 3 | $0 | $0 | 2024-05-06 |
| DelAversano Robert J | Principal Financial Officer | 1 | $0 | $0 | 2024-05-06 |
| Macdonald R. Loch | Chief Medical Officer | 2 | $0 | $0 | 2024-05-06 |
| Kottayil George | Director | 2 | $0 | $0 | 2023-12-19 |
| Kavuru Vimal | Director, 10% Owner | 6 | $1.31M | $0 | 2023-12-19 |
| NEUGEBOREN EDWARD | Director | 1 | $0 | $0 | 2023-12-19 |
| DAVIS A BRIAN | Director | 1 | $0 | $0 | 2023-12-19 |
| Olds Donald | Director | 4 | $781 | $0 | 2023-08-31 |
| Derby Michael | Director | 2 | $0 | $0 | 2023-07-14 |
| Canan John | Director | 2 | $0 | $0 | 2022-09-28 |
| Ford Brian D. | CHIEF FINANCIAL OFFICER | 2 | $0 | $0 | 2022-06-22 |
| D'Alvise Janelle | PRESIDENT & CEO | 2 | $0 | $0 | 2022-06-22 |
| Lemieux Pierre | COO, Canada & CSO | 2 | $0 | $0 | 2022-06-22 |
| HASELTINE WILLIAM A | Director | 1 | $0 | $0 | 2021-11-12 |
| Carter Roderick Noel | Director | 1 | $0 | $0 | 2021-11-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Kohli Prashant | Chief Executive Officer | A Award deriv | 2024-05-06 | 2024-05-08 | 128,770 | — | $0 | 128,770 | SEC↗ |
| DelAversano Robert J | Principal Financial Officer | A Award deriv | 2024-05-06 | 2024-05-08 | 4,500 | — | $0 | 4,500 | SEC↗ |
| Macdonald R. Loch | Chief Medical Officer | A Award deriv | 2024-05-06 | 2024-05-08 | 25,380 | — | $0 | 25,380 | SEC↗ |
| Kumar Amresh | VP Clinical Operations | A Award deriv | 2024-05-06 | 2024-05-08 | 19,740 | — | $0 | 19,740 | SEC↗ |
| D'Andrea Carrie | VP Program Management | A Award deriv | 2024-05-06 | 2024-05-08 | 19,740 | — | $0 | 19,740 | SEC↗ |
| Kumar Amresh | VP Program Management | A Award deriv | 2024-05-06 | 2024-05-10 | 19,740 | — | $0 | 19,740 | SEC↗ |
| D'Andrea Carrie | VP Clinical Operations | A Award deriv | 2024-05-06 | 2024-05-10 | 19,740 | — | $0 | 19,740 | SEC↗ |
| Kohli Prashant | Chief Executive Officer | A Award deriv | 2023-12-19 | 2023-12-20 | 41,668 | — | $0 | 41,668 | SEC↗ |
| DAVIS A BRIAN | Director | A Award deriv | 2023-12-19 | 2023-12-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NEUGEBOREN EDWARD | Director | A Award deriv | 2023-12-19 | 2023-12-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Kottayil George | Director | A Award deriv | 2023-12-19 | 2023-12-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Kavuru Vimal | Director, 10% Owner | A Award deriv | 2023-12-19 | 2023-12-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kavuru Vimal | Director, 10% Owner | P Buy deriv | 2023-09-25 | 2023-09-27 | 422,732 | $0.13 | $55.0K | 422,732 | SEC↗ |
| Kavuru Vimal | Director, 10% Owner | P Buy | 2023-09-25 | 2023-09-27 | 676,371 | $1.85 | $1.25M | 1,188,076 | SEC↗ |
| Olds Donald | Director | P Buy | 2023-08-31 | 2023-09-05 | 381 | $2.05 | $781 | 381 | SEC↗ |
| Kohli Prashant | Chief Executive Officer | A Award deriv | 2023-07-14 | 2023-07-18 | 208,334 | — | $0 | 208,334 | SEC↗ |
| Kumar Amresh | VP Program Management | A Award deriv | 2023-07-14 | 2023-07-18 | 42,000 | — | $0 | 42,000 | SEC↗ |
| D'Andrea Carrie | VP Clinical Operations | A Award deriv | 2023-07-14 | 2023-07-18 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Macdonald R. Loch | Chief Medical Officer | A Award deriv | 2023-07-14 | 2023-07-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Olds Donald | Director | A Award deriv | 2023-07-14 | 2023-07-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Kavuru Vimal | Director | A Award deriv | 2023-07-14 | 2023-07-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Derby Michael | Director | A Award deriv | 2023-07-14 | 2023-07-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Derby Michael | Director | A Award deriv | 2022-09-28 | 2022-09-30 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Canan John | Director | A Award deriv | 2022-09-28 | 2022-09-30 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Olds Donald | Director | A Award deriv | 2022-09-28 | 2022-09-30 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Kavuru Vimal | Director | A Award deriv | 2022-09-28 | 2022-09-30 | 45,000 | — | $0 | 45,000 | SEC↗ |
| D'Alvise Janelle | PRESIDENT & CEO | A Award deriv | 2022-06-22 | 2022-06-23 | 560,000 | — | $0 | 560,000 | SEC↗ |
| Ford Brian D. | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-06-22 | 2022-06-23 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Kottayil George | COO, US | A Award deriv | 2022-06-22 | 2022-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Lemieux Pierre | COO, Canada & CSO | A Award deriv | 2022-06-22 | 2022-06-23 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Canan John | Director | A Award deriv | 2021-11-12 | 2021-11-16 | 42,100 | — | $0 | 42,100 | SEC↗ |
| Carter Roderick Noel | Director | A Award deriv | 2021-11-12 | 2021-11-16 | 42,100 | — | $0 | 42,100 | SEC↗ |
| D'Alvise Janelle | PRESIDENT & CEO | A Award deriv | 2021-11-12 | 2021-11-16 | 655,500 | — | $0 | 655,500 | SEC↗ |
| Ford Brian D. | CHIEF FINANCIAL OFFICER | A Award deriv | 2021-11-12 | 2021-11-16 | 287,900 | — | $0 | 287,900 | SEC↗ |
| HASELTINE WILLIAM A | Director | A Award deriv | 2021-11-12 | 2021-11-16 | 42,100 | — | $0 | 42,100 | SEC↗ |
| Kavuru Vimal | Director | A Award deriv | 2021-11-12 | 2021-11-16 | 42,100 | — | $0 | 42,100 | SEC↗ |
| Lemieux Pierre | COO, Canada & CSO | A Award deriv | 2021-11-12 | 2021-11-16 | 287,900 | — | $0 | 287,900 | SEC↗ |
| Olds Donald | Director | A Award deriv | 2021-11-12 | 2021-11-16 | 42,100 | — | $0 | 42,100 | SEC↗ |